SLC12A5 and Alzheimer disease: With respect to AD, Aβ42 increases NKCC1 in mouse hippocampus (Lam et al., 2022), and APP expression decreases KCC2 in cortical cells without modifying NKCC1 (Doshina et al., 2017).